Horizon Therapeutics plc to Present at the 38th Annual J.P. Morgan Healthcare Conference
December 09 2019 - 8:00AM
Business Wire
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the
Company will participate in the 38th Annual J.P. Morgan Healthcare
Conference. Timothy Walbert, chairman, president and chief
executive officer will present at 5 p.m. PT on Jan. 15, 2020.
The conference presentation will be webcast live and may be
accessed by visiting Horizon's website at
http://ir.horizontherapeutics.com. A replay of the webcast will be
available for the event.
About Horizon
Horizon is focused on researching, developing and
commercializing medicines that address critical needs for people
impacted by rare and rheumatic diseases. Our pipeline is
purposeful: we apply scientific expertise and courage to bring
clinically meaningful therapies to patients. We believe science and
compassion must work together to transform lives. For more
information on how we go to incredible lengths to impact lives,
please visit www.horizontherapeutics.com, follow us @HorizonNews on
Twitter, like us on Facebook or explore career opportunities on
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191209005194/en/
Investors: Tina Ventura Senior Vice President, Investor
Relations investor-relations@horizontherapeutics.com
Ruth Venning Executive Director, Investor Relations
investor-relations@horizontherapeutics.com
U.S. Media: Geoff Curtis Executive Vice President,
Corporate Affairs & Chief Communications Officer
media@horizontherapeutics.com
Ireland Media: Ray Gordon Gordon MRM ray@gordonmrm.ie
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Sep 2023 to Sep 2024